OBESE
Clinical trials for OBESE explained in plain language.
Never miss a new study
Get alerted when new OBESE trials appear
Sign up with your email to follow new studies for OBESE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New weekly injection aims to help people lose weight in major trial
Disease control Recruiting nowThis study is testing whether a new weekly injection called HM15275 can help adults with obesity or overweight lose weight and is safe to use. About 250 participants without diabetes will receive either the drug or a placebo (inactive shot) for 36 weeks to compare results. The ma…
Matched conditions: OBESE
Phase: PHASE2 • Sponsor: Hanmi Pharmaceutical Company Limited • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Diabetes drug trial aims to shed pounds and control blood sugar
Disease control Recruiting nowThis study is testing whether a new medication called aleniglipron is safe and helps with weight loss and blood sugar control in adults with type 2 diabetes who are overweight or have obesity. About 50 participants will take either the drug or a placebo (inactive pill) daily for …
Matched conditions: OBESE
Phase: PHASE2 • Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Can texts and counseling help NYC drivers shed pounds?
Disease control Recruiting nowThis study is testing a weight loss program designed for taxi and ride-share drivers in New York City. It will compare four different support methods—like personal counseling, text messages, and weekly calls—to see which combination works best to help drivers lose at least 5% of …
Matched conditions: OBESE
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
New nose scope could slash costs and wait times for GI checks
Diagnosis Recruiting nowThis study is testing a new, very thin endoscope that goes through the nose instead of the mouth and doesn't require sedation. It aims to see if this method is a good, cheaper, and faster way to check for stomach and esophagus problems in people enrolled in a weight management pr…
Matched conditions: OBESE
Phase: NA • Sponsor: Christopher C. Thompson, MD, MSc • Aim: Diagnosis
Last updated Mar 16, 2026 15:26 UTC
-
First test of new Weight-Loss shot begins in humans
Knowledge-focused Recruiting nowThis is the first study in humans to test the safety of a new experimental injection called HM17321, which is being developed for obesity. About 40 healthy adults will receive a single injection to see how their bodies react and process the drug. The main goal is to check for sid…
Matched conditions: OBESE
Phase: PHASE1 • Sponsor: Hanmi Pharmaceutical Company Limited • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:35 UTC
-
Weight loss drug could protect brain function in chronic illness
Knowledge-focused Recruiting nowThis study is testing whether a weight loss medication called liraglutide (Saxenda) affects brain health markers in people with multiple sclerosis, long COVID, or leukemia in remission who also have obesity and cognitive problems. Researchers will measure changes in a protein cal…
Matched conditions: OBESE
Phase: EARLY_PHASE1 • Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated Mar 20, 2026 14:48 UTC